BiomX Enters Collaboration with Johnson & Johnson Innovation for Discovery of Microbiome-based Biomarkers for IBD
Synlogic Expands Capabilities in Manufacturing with the Appointment of Head of Technical Operations and Establishment of In-house Production of Clinical Trial Material for its Synthetic BioticTM Medicines
Novo Nordisk purchases Berkeley Lights’ Beacon® Optofluidic platform for cell line development and antibody discovery
Berkeley Lights Launches Plasma B Cell Antibody Discovery Workflow on the Beacon® Optofluidic Platform
Intellia Therapeutics and Novartis Expand Cell Therapy Collaboration to Pursue CRISPR/Cas9-based Genome Editing in Additional Stem Cell Population
Precision BioSciences Receives FDA Authorization to Initiate Clinical Study of Gene Edited Cancer Immunotherapy
Torrey Pines Investment’s i2020 Accelerator to Advance Snap Bio’s Selective Kinase Inhibitor Platform for Treatment of Endodermal Cancers and Autoimmune Diseases
Synlogic Presents Preclinical Data from First Synthetic BioticTM Clinical Candidate in Immuno-Oncology at the Society for Immunotherapy of Cancer’s (SITC) 33rd Annual Meeting
